Literature DB >> 27074278

Adjuvant Pericardial Sac Restraining in Heart Failure Treatment. A Medical Hypothesis Illustrated by a Case Report.

Paulo Roberto Barbosa Evora1, Minna Moreira D Romano2, Luis Gustavo Gali2, André Schmidt2, Alfredo José Rodrigues1.   

Abstract

Ventricular constraint therapy has been used to prevent and reverse the progression of heart failure in ischemic and nonischemic cardiomyopathies. We hypothesized that ventricular restraint should be tried by closing the pericardium that was previously opened following left ventricle topographical projection. The surgical technique presentation is illustrated by a remarkable 13-year outcome of one patient with dilated cardiomyopathy treated surgically by mitral prosthesis, Cox/Maze III surgery to treat atrial fibrillation, and associated to the ventricular constraint using the patient's own pericardium. The ventricular pericardial restraint role is unclear, since the patient had multiple corrections that could be responsible for the good outcome; however it is viable deserving investigations.

Entities:  

Mesh:

Year:  2016        PMID: 27074278      PMCID: PMC5062694          DOI: 10.5935/1678-9741.20160004

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  9 in total

1.  Partial left ventriculectomy to improve left ventricular function in end-stage heart disease.

Authors:  R J Batista; J L Santos; N Takeshita; L Bocchino; P N Lima; M A Cunha
Journal:  J Card Surg       Date:  1996 Mar-Apr       Impact factor: 1.620

Review 2.  Clinical epidemiology of heart failure: public and private health burden.

Authors:  J J McMurray; M C Petrie; D R Murdoch; A P Davie
Journal:  Eur Heart J       Date:  1998-12       Impact factor: 29.983

3.  Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial.

Authors:  Michael A Acker; Steven Bolling; Richard Shemin; James Kirklin; Jae K Oh; Douglas L Mann; Mariell Jessup; Hani N Sabbah; Randall C Starling; Spencer H Kubo
Journal:  J Thorac Cardiovasc Surg       Date:  2006-07-31       Impact factor: 5.209

4.  Guideline for the surgical treatment of atrial fibrillation.

Authors:  Joel Dunning; Myura Nagendran; Ottavio R Alfieri; Stefano Elia; A Pieter Kappetein; Ulf Lockowandt; George E Sarris; Phillippe H Kolh
Journal:  Eur J Cardiothorac Surg       Date:  2013-08-16       Impact factor: 4.191

5.  Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial.

Authors:  Michael A Acker; Mariell Jessup; Steven F Bolling; Jae Oh; Randall C Starling; Douglas L Mann; Hani N Sabbah; Richard Shemin; James Kirklin; Spencer H Kubo
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01-26       Impact factor: 5.209

6.  Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy.

Authors:  S F Bolling; G M Deeb; L A Brunsting; D S Bach
Journal:  J Thorac Cardiovasc Surg       Date:  1995-04       Impact factor: 5.209

7.  Mitral valve repair in cardiomyopathy.

Authors:  F Y Chen; D H Adams; S F Aranki; J J Collins; G S Couper; R J Rizzo; L H Cohn
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

8.  Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure.

Authors:  T Kono; H N Sabbah; H Rosman; M Alam; S Jafri; S Goldstein
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

Review 9.  The current therapy for mitral regurgitation.

Authors:  Blase A Carabello
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.